Filing Details

Accession Number:
0000792977-19-000113
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-05-29 16:27:37
Reporting Period:
2019-05-28
Accepted Time:
2019-05-29 16:27:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
792977 Amag Pharmaceuticals Inc. AMAG Pharmaceutical Preparations (2834) 042742593
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1643127 Julie Krop C/O Amag Pharmaceuticals, Inc.
1100 Winter Street
Waltham MA 02451
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-05-28 10,000 $9.91 81,399 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The shares purchased on this date were purchased in multiple transactions. The actual purchase prices range from $9.85 to $9.96, inclusive. Upon request by the Securities and Exchange Commission, the issuer, or any security holder of the issuer, the reporting person will provide full information regarding the number of shares purchased at each price.